Development and validation of a 24-h predictive model for hypertriglyceridemic moderately severe acute pancreatitis: a single-center retrospective study - Scorecard - MDSpire

Development and validation of a 24-h predictive model for hypertriglyceridemic moderately severe acute pancreatitis: a single-center retrospective study

  • By

  • Songlong Yang

  • Chaoqun Li

  • Kaiping Zeng

  • Minguang Zhang

  • Wenrong Wang

  • July 2, 2026

  • 0 min

Share

Clinical Scorecard: Creation and assessment of a 24-hour risk prediction model for moderately severe acute pancreatitis due to hypertriglyceridemia: a retrospective study from a single center

At a Glance

CategoryDetail
ConditionModerately Severe Acute Pancreatitis (MSAP) due to Hypertriglyceridemia
Key MechanismsSystemic inflammatory response syndrome (SIRS) and elevated triglyceride levels
Target PopulationPatients with hypertriglyceridemia-induced acute pancreatitis
Care SettingSingle-center retrospective study

Key Highlights

  • Developed a risk prediction model for MSAP within 24 hours of admission
  • Identified SIRS and elevated triglyceride levels as independent risk factors
  • Model demonstrated an AUC of 0.909 in the validation cohort
  • Sensitivity of 86.2% and specificity of 90.9% for the prediction model
  • Comparison with the BISAP score showed superior performance

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of acute pancreatitis requires characteristic abdominal pain, elevated serum amylase/lipase, and imaging findings.

Management

  • Early identification of patients at high risk of progressing to MSAP for timely clinical intervention.

Monitoring & Follow-up

  • Monitor triglyceride levels and SIRS criteria within the first 24 hours after admission.

Risks

  • Patients with HTG-AP have a higher risk of organ failure and local complications.

Patient & Prescribing Data

146 patients with hypertriglyceridemia-induced acute pancreatitis

A 24-hour triglyceride level below 18.41 mmol/L indicates a lower risk of progression to MSAP.

Clinical Best Practices

  • Utilize the developed prediction model for early risk stratification in HTG-AP patients.
  • Incorporate SIRS and triglyceride levels in clinical assessments.

Related Resources & Content

Original Source(s)

Related Content